Research > ETFs > ETF / ETP Commentary > 

Why It's Time to Add Equities Exposure in Active ETFs

Investors are used to a swirling mass of scary headlines and geopolitical and monetary risk. Yen carry trade and yield concerns, however, may have some feeling of trepidation. Despite those risks, equities continue to appeal. Indeed, T. Rowe Price’s Asset Allocation Committee recently moved to an overweight in equities relative to bonds, boosting the case for exposure in active equities ETFs like the T. Rowe Price U.S. Equity Research ETF (TSPA B).Key Takeaways: T. Rowe Price’s Asset Allocation Committee has upped its exposure to equities relative to bonds. The active ETF TSPA has returned 12.8% YTD according to ETF Database data, offering a route into an expanded market. Stable valuations and solid earnings growth have helped lift the appeal of equities among T. Rowe Price’s leaders. A piece by T. Rowe Price Capital Markets Strategist Tim Murray explored that recent shift towards an equities overweight. In his analysis, Murray explained the reasoning behind the allocation committee’s move. He cited strong earnings, broadening growth signals, and stable valuations as factors undergirding the appeal. “The most compelling part of the equity story continues to be earnings,” he wrote. “Forward earnings expectations are exceptionally strong across investment styles, market capitalizations, and geographies. Not surprisingly, areas with the greatest exposure to the ongoing AI infrastructure build‑out continue to lead the way.” “But perhaps even more encouraging is the breadth of this strength,” he added. “Areas with much less exposure to AI are also expected to generate double‑digit earnings growth. What is particularly remarkable is that this is not occurring during a recovery from recession.” At the same time, he noted that earnings growth has displayed notable breadth. Areas outside of the AI zeitgeist are seeing growth projections without seeing valuations overheat. Murray identified valuations as “surprisingly disciplined.” “In fact, the two areas with the strongest expected earnings growth—U.S. large‑cap growth and emerging markets—have actually seen their valuation multiples decline modestly,” he said. See more: How Active Tech ETF TTEQ Almost Doubled AUM in 3 Months Investors, then, may want to consider ways to expand their equities exposure as opportunities broaden. One way to do so is through active ETFs like the TSPA. The fund charges a 34 basis point fee for an active, research-driven approach to broad market exposure. The strategy has returned 12.8% YTD, and could prove a solid active ETF candidate. Where passive mutual funds must track their indexes precisely, TSPA’s more flexible approach has the ability to overweight or underweight holdings, while also adding additional names beyond the index. What’s more, ETFs offer some notable tax advantages. With TSPA’s remit to pursue performance, it may make a solid satellite option for a broadening market. For more news, information, and analysis, visit our Active ETF Content Hub.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.